Godwin W Nchinda Photo
Godwin W Nchinda
Centre International de Reference Chantal Biya (CIRCB)
Yaounde
Biography
Dr. Godwin W Nchinda (Ph.D) is Senior Immunologist CIRCB and Deputy Director General Head of CIRCB Vaccinology Laboratory Head of CIRCB Biobanking Laboratory For the last twenty four years I have focused my attention to developing model vaccines that could be easily translated into clinics against infectious diseases and tumors. I studied Microbiology in the University of Calabar, Nigeria and then spent four years thereafter in the University of Nigeria, Nsukka, Nigeria working on an NIH Grant where we developed a feed based vaccine against Newcastle disease virus infections in free range Chickens. During my Ph.D thesis (1998-2001) I learned how to design and evaluate model SIV/HIV vaccines under the mentorship of Dr. K. Überla, Professor of Molecular Virology in the University of Leipzig Germany. I next did a two year postdoc in the Ruhr University Bochum, Germany where we continued characterizing HIV/SIV vaccines. During the next 7 years (2003-2010), I worked under the mentorship of Dr. Ralph Steinman (2011 Nobel prize for Medicine) of the Rockefeller University USA, where we developed new forms of HIV, TB, Malaria and Tumor vaccines by harnessing Dendritic cells. In 2008 I was certified as a clinical and translational research scientist by the Rockefeller University. In 2010 I relocated to CIRCB, Yaounde Cameroon where we are now optimizing dendritic cell targeted vaccines for clinical evaluation in Africa. The first in human evaluation of a Cameroon developed HIV-1 vaccine is envisaged in 2017. In addition we are also studying the phenotypic and functional properties of various immune’s cells in the context of co-morbidies with HIV-1 infection. We are looking particularly at the impact of malaria, HBV, HCV, HPV and TB in the long term management of HIV-1 especially in remote areas of Africa. We are also actively training young research scientists at the Msc and Ph.D level to perform cutting edge science. Our work has been funded by TWAS, EDCTP, Canada grand challenge, Italy, Germny, Korea and Norway. Never the less the the Cameroonian government has remain our greatest funder.
As a Speaker
CPD Accredited
Global Congress on
Bacteriology and Infectious Diseases
Conference Track Name : Virology
Title : null
CPD Accredited Global Summit on Immunology and Cell Biology
Conference Track Name : Immunopathology and Immunodeficiencies
Title : null
Research Interests
Targeting conserved broadly Neutralizing Epitopes within HIV-1 Envelope gp41 MPER as vaccine immunogens for seronegative partners of HIV-1 discordant couples.

Upcoming Events
View All

Allied Academies Global Conference Directory

Copyright © 2019-2020 Allied Academies, All Rights Reserved.